Meredith A L, Upadhyaya M, Harper P S
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff.
BMJ. 1988 Oct 1;297(6652):843-6. doi: 10.1136/bmj.297.6652.843.
The development of a molecular genetics diagnostic service over a three year period was studied in a National Health Service region with a population of three million. Starting from a time when few diagnostic applications were possible, the number of disorders and the overall demand had grown rapidly. Conditions for which molecular genetic diagnosis had been provided included Duchenne and Becker muscular dystrophy, myotonic dystrophy, Huntington's disease, and cystic fibrosis. Of 405 requests for diagnosis, 151 (37%) related to determination of carrier state, 187 (46%) to determining the feasibility of future prenatal diagnosis, and 67 (17%) were prenatal diagnostic biopsy samples, almost exclusively of first trimester chorion. DNA samples for future diagnostic use with a wide range of genetic disorders had also been banked. The study showed a need for close integration with clinical genetics services to allow satisfactory genetic counselling and interpretation of risks.
在一个拥有三百万人口的国民医疗服务体系(NHS)地区,对一项为期三年的分子遗传学诊断服务的发展情况进行了研究。从几乎没有诊断应用的时期开始,疾病种类和总体需求迅速增长。已提供分子遗传学诊断的疾病包括杜氏和贝克型肌营养不良症、强直性肌营养不良症、亨廷顿舞蹈症和囊性纤维化。在405例诊断请求中,151例(37%)与携带者状态的确定有关,187例(46%)与确定未来产前诊断的可行性有关,67例(17%)是产前诊断活检样本,几乎全是孕早期绒毛膜样本。还储存了用于未来对多种遗传疾病进行诊断的DNA样本。该研究表明,需要与临床遗传学服务紧密整合,以便进行令人满意的遗传咨询和风险解读。